1mg

Tata 1mg received board approval for offline expansion, which will be funded through debt, while BigBasket plans to raise $80-100 million through a mix of equity and debt

Tata 1mg now holds 31% of the market share, up from 19% in October 2022. PharmEasy's market share decreased to 15% from 33% in the same period

Startups need to live up to higher standards of corporate governance, and failure of a business is not as big an issue as ethics and morality-related concerns, Tata 1mg co-founder Prashant Tandon said on Wednesday. He advised startups not to get swayed by short-term temptations, saying long-term enterprises cannot be built through shortcuts. "Businesses not working is not a problem, governance-related and ethics morality-related issues are not acceptable," he told PTI on the sidelines of the IAMAI Digital Health Summit. Tandon said that governance needs to be "front and center" for startups and that when governance is strong, capital flows better. He hoped that the startup ecosystem lives up to higher standards. Addressing the recent governance and financial lapses faced by startups such as Byju's, he said, "As an ecosystem we are waking up to a lot of issues around governance controls". He acknowledged that the late-stage startup ecosystem has become more challenging. "With th

Tata group-owned online pharmacy 1mg's revenue from operations rose 65.7 per cent to Rs 222.10 crore in FY22, while its net loss narrowed to Rs 146.30 crore, according to data sourced by business intelligence platform Tofler. Tata 1mg's revenue from operations in FY21 stood at Rs 134.04 crore and its net loss was Rs 281.41 crore. Its other income for the financial year ended March 31, 2021, was Rs 24.14 crore. Tata 1mg's total income during FY22 was at Rs 246.25 crore, up 44.19 per cent from Rs 170.78 crore in the previous year. In FY22, facilitation fees accounted for Rs 23.15 crore of revenue and Rs 139.64 crore came from lab test receipts. Tata 1mg is a leading digital consumer healthcare platform providing services such as e-pharmacy, where it delivers medicines and health products at home from licensed pharmacies in over 1,000 cities. It also provides diagnostic services from certified labs and online doctor consultations. The company was incorporated on April 20, 2015. From

Funding round was led by Tata Digital; Tata 1mg has become 105th unicorn in India

Since Tata 1mg is focused on online diagnostics and home collection of samples, it has third-party partners for radiology tests

Under the deal, B Medical Systems will back 1MG's jab campaign across metros and Tier-1 cities; 1MG will also get access to ultra-low freezers and transport boxes for storage and transport of vaccines

Apollo will merge its online and offline pharmacy businesses (excluding hospital pharmacies) and telemedicine verticals into a single entity called Apollo HealthCo

1mg reported revenue of Rs 357.9 crore for 2019-20 (FY20), and Rs 266 crore for the period from April 1, 2020, to January 31, 2021

The investment in 1MG is in line with Tata Group's vision of creating a digital ecosystem which addresses the consumer needs across categories in a unified manner

The move ahead of the Gurugram-based firm's acquisition by the Tata Sons arm

Columbia Pacific Communities is a senior living community operator with close to 1,600 residential units under management in five cities and nine communities across India

Only 5% willing to shell out more than Rs 2,000, about 84% willing to be immunised

The service would allow customers to order prescription-based medication in addition to over-the-counter medicines, basic health devices and Ayurveda medication from certified sellers

Gurugram-based 1mg, for example, is looking to immediately hire 500 people and another 1,000 over the next 2-3 months

International Finance Corporation (IFC) will be one of the investors

This is HBM's first direct investment in a digital health company in this region

1mg has made buying medicines easy and it aims to do more in online health care